← Back to Brace Pharma Capital Profile
What sectors does Brace Pharma Capital invest in?
Brace Pharma Capital primarily invests in the biotech and pharmaceutical sectors.
They focus on companies developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
Investor Profile: Brace Pharma Capital on EzFunding
Brace Pharma Capital is a strategic investment firm focused on innovative, life-changing therapies for diseases with high unmet medical needs. Formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors, they provide strategic guidance, industry connections, and operational support to their portfolio companies.
- Invests in early-stage biotech and pharmaceutical companies
- Focuses on innovative therapies and technologies
- Provides strategic, operational, and networking support
- Typically invests in seed to Series A funding rounds
More Questions About Brace Pharma Capital
- Who is Brace Pharma Capital?
Brace Pharma Capital is a strategic investment firm focused on innovative, life-changing therapies for diseases with high unmet medical needs, formed by EMS S/A and high net worth biotech investors.
The firm invests in early-stage biotech and pharmaceutical companies, providing both financial and strategic support to help these companies develop groundbreaking therapies.
Investor Profile: Brace Pharma Capital on EzFunding
- What is the investment strategy of Brace Pharma Capital?
Brace Pharma Capital focuses on supporting early-stage biotech and pharmaceutical companies that are developing innovative therapies and technologies aimed at addressing significant unmet medical needs.
They target founders with a robust vision for groundbreaking therapies and invest primarily in the biotech and pharmaceutical sectors.
Investor Profile: Brace Pharma Capital on EzFunding
- What are the investment stages for Brace Pharma Capital?
Brace Pharma Capital invests in the pre-seed, seed, and Series A stages.
They provide financial and strategic support to help early-stage companies develop and bring innovative therapies to market.
Investor Profile: Brace Pharma Capital on EzFunding
- What is the typical check size for Brace Pharma Capital?
The typical check size for Brace Pharma Capital ranges from $50,000 to $1,000,000 USD.
This range allows them to support a variety of early-stage companies in the biotech and pharmaceutical sectors.
Investor Profile: Brace Pharma Capital on EzFunding
- Does Brace Pharma Capital accept cold outreach?
No, Brace Pharma Capital does not accept cold outreach.
They prefer to engage with founders through strategic partnerships and existing networks rather than unsolicited proposals.
Investor Profile: Brace Pharma Capital on EzFunding
- Who are the key team members at Brace Pharma Capital?
The key team members at Brace Pharma Capital include Daniel E. Salazar, Ph.D., Todd Brady, Carlos Sanchez, Raymond F. Schinazi, Ph.D., D.Sc.
These individuals bring extensive experience and expertise in the biotech and pharmaceutical industries to the firm.
Investor Profile: Brace Pharma Capital on EzFunding
Verification Confidence: 95% | Source: summary | Entity: Brace Pharma Capital